ArticleOncoimmunology2023
Trial watch: Toll-like receptor ligands in cancer therapy.
Julie Le Naour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it
ArticleOncoimmunology2023
Julie Le Naour et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.